Lanean...
Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options
Background: Gaucher disease is a rare lysosomal storage disease resulting from a deficiency or reduced activity in the acid β-glucocosidase enzyme. Only 1 treatment option was available for 15 years, but several new treatment options have come to market since 2003. Objective: The article will detail...
Gorde:
| Argitaratua izan da: | Hosp Pharm |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Thomas Land Publishers, Inc.
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4981103/ https://ncbi.nlm.nih.gov/pubmed/27559188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj5107-553 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|